• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Eagle Announces Laboratory Test Results Demonstrating In Vitro RYANODEX®

    BUSINESSWIRE

    Results of Pivotal Phase 3 Reblozyl® (luspatercept-aamt) MEDALIST Trial

    BUSINESS WIRE

    Enforcement Report - Week of May 8, 2019

    FDA

    Eagle`s Announces +ve Results of a Study in Partnership with the U.S. Military

    BUSINESSWIRE

    Eagle Pharmaceuticals Announces Fifth Orange Book Listed Patent for RYANODEX

    BUSINESSWIRE

    Eagle Pharma shares tank after FDA stiff its application for heat stroke remedy

    ENDPTS

    Hikma Pharm’s Generic Dantrolene Sodium Receives Approval In US

    FDA

    Eagle Sues FDA Over BENDEKA Orphan Drug Exclusivity in Depomed-like Lawsuit

    FDA LAW BLOG

    Mylan Institutional`s Generic Dantrolene Sodium approved in US as postsynaptic muscle relaxant

    FDA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    FDA Grants Seven Years’ Market Exclusivity To Eagle Pharmaceuticals (EGRX)’ Ryanodex For The Treatment Of Malignant Hyperthermia

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.